MarginsXMarginsX
Home › Markets › Health Care › TRAW

Traws Pharma Inc. (TRAW)

TRAW trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.2600
+3.59% on the day
Market cap
$4.0M
Nano cap
Revenue · 2025
$2.8M
+1134.5% on 2024
Net income · 2025
$9.2M
328.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1130598/000110465926043832/0001104659-26-043832-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTRAW on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2013
SEC CIK0001130598
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.8M
Net income$9.2M
Operating income-$17.9M
Net margin328.7%
Operating margin-640.7%
Revenue growth+1134.5%
Cash$3.8M
Total assets$10.6M
P/E (computed)0.4×
P/S (computed)1.4×

Warning signs

Cash runway
3.6 months
$5.0M cash at June 30, 2026
Share count, 1 year
+117.6%
2025-08-12 to 2026-08-12 · +1731.5% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$998K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result of these conditions, substantial doubt exists about the Company's ability to continue as a going concern."
10-Q 2026-08-14
Cash and burn$5.0M cash; operating cash flow -$4.2M a quarter.Report 2026-06-30
Shares outstanding15,368,277 (2026-08-12); 7,063,829 a year earlier; 20,977,625 three years earlier. 3y figure adjusted for splits (1-for-25 overall).Cover page 2026-08-12
Reverse splits, 3 years1; latest 1-for-25 on 2024-09-23Source 2024-09-23
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-07-10
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-07-31
AuditorKPMG LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-05-14
Late filings, 12 months1 NT noticeNT 10-K 2026-03-31
Insider trades, 12 monthsBought $998K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$3.1M-$7.5M$5.0MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$7.1M-$2.6M$3.1MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
$0-$7.4M-$2.8M$3.8MNo debt tags$2.8M10-K 2026-04-15
Q3 2025
2025-09-30
$0-$4.0M-$4.0M$6.4MNo debt tags$2.8M10-Q 2025-11-13
Q2 2025
2025-06-30
$2.7M-$915K-$6.0M$13.1MNo debt tags$2.9M10-Q 2026-08-14
Q1 2025
2025-03-31
$57K$21.5M-$5.4M$15.9MNo debt tags$227K10-Q 2026-05-15
Q4 2024
2024-12-31
$56K-$29.9M-$4.0M$21.3MNo debt tags$226K10-K 2026-04-15
Q3 2024
2024-09-30
$57K-$8.5M-$11.5M$5.4MNo debt tags$226K10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-11-16
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-08-14
Latest current report
FORM 8-K
8-K2026-11-16
Latest proxyDEFA14A2026-10-20

Source: SEC EDGAR submissions feed, 994 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+13.6%
1 month-39.0%
3 months-58.3%
Year to date-77.9%
1 year-85.9%
From 52-week high-91.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IMNNImunon Inc.$0.5940-5.56%$3.9M
GELSGelteq Limited$0.3589-5.63%$3.8M
AZTRAzitra Inc$0.6270+3.06%$3.8M
XTLBXTL Biopharmaceuticals Ltd.$1.54-3.75%$3.8M
BGMSBio Green Med Solution Inc.$0.6502+1.55%$4.3M
KPRXKiora Pharmaceuticals Inc.$0.9820-20.16%$4.3M
NCNANuCana plc American Depositary Share$0.8631-7.46%$4.4M
XBIOXenetic Biosciences Inc.$1.49-10.24%$3.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier